Biocompatibles to Buy CellMed for up to €22.2 Million

Biocompatibles International, the medical device company focused on the treatment of cancer and cardiovascular disease, has conditionally agreed to acquire Germany's CellMed for up to €22.2 million in cash and shares.

interactive investor (http://www.iii.co.uk/news/?type=afxnews&articleid=5227852&subject=companies&action=article)